Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Non Operating Investment Income (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Non Operating Investment Income for 2 consecutive years, with -$16000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income rose 91.16% to -$16000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$117000.0 through Dec 2025, down 209.35% year-over-year, with the annual reading at -$117000.0 for FY2025, 209.35% down from the prior year.
  • Non Operating Investment Income for Q4 2025 was -$16000.0 at Pyxis Oncology, down from $74000.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $453000.0 in Q3 2024, with the low at -$181000.0 in Q4 2024.